Lee, C. Y., Andorsky, D., Boccia, R. V., Torres, A. L., Vaidya, R., Gandhi, M., Naik, S., Haydu, J. E., Ibrahimi, S., Madueno, F. M. V., Sundaram, S., Sahnoune, I., Jiang, T., Zhang, M., Vindeloev, S. D., Sharman, J. P. (2026). EPCORE NHL-6: Phase 2 study of subcutaneous (SC) epcoritamab as outpatient treatment for 2L+ relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19003